Triptans and Lasmiditan Are Safe and Effective in Patients with Migraine Attacks Associated with Neurodevelopmental Disorders: A Single-Center Prospective Clinical Case Series. [PDF]
Brain SciShibata Y.
europepmc +1 more source
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans. [PDF]
Neurol TherGoadsby PJ +14 more
europepmc +1 more source
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? [PDF]
Pediatric Health Med Ther, 2022 Gibler RC +4 more
europepmc +1 more source
Evidence-based symptomatic treatment of migraine
Symptomatic treatment of migraine includes patient education, mainly to avoid medication overuse and known trigger factors, as well as pharmaceutical and nonpharmaceutical interventions.
Mitsikostas, Dimos D., Ward, Thomas N.
core +1 more source
Innovative treatments for migraine: a new era. [PDF]
Ther Adv Neurol DisordPistoia F.
europepmc +1 more source
The use of triptans, opioids, and other rescue medications among patients with migraine prescribed calcitonin gene-related peptide inhibitors for migraine prophylaxis. [PDF]
J Manag Care Spec PharmNguyen JL +6 more
europepmc +1 more source
Migraine: from pathophysiology to treatment. [PDF]
J Neurol, 2023 Puledda F +3 more
europepmc +1 more source
Iron concentration in the ventral pallidum of chronic migraine with medication-overuse headache. [PDF]
J Headache PainXu X +13 more
europepmc +1 more source
Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry. [PDF]
J Headache Pain, 2023 Ruscheweyh R +11 more
europepmc +1 more source
Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics. [PDF]
World J Clin PediatrAl-Beltagi M.
europepmc +1 more source